Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

GeneDx Holdings (WGS) Non-Current Deffered Revenue (2020 - 2021)

GeneDx Holdings has reported Non-Current Deffered Revenue over the past 2 years, most recently at $295.0 million for Q2 2021.

Quarterly Non-Current Deffered Revenue changed N/A to $295.0 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $295.0 million through Jun 2021, changed N/A year-over-year, with the annual reading at $132.0 million for FY2020, N/A changed from the prior year.
Non-Current Deffered Revenue was $295.0 million for Q2 2021 at GeneDx Holdings, down from $297.0 million in the prior quarter.
Over five years, Non-Current Deffered Revenue peaked at $297.0 million in Q1 2021 and troughed at $15.5 million in Q3 2020.